Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

The evolutionary potential of an insect invader under climate change.

Logan ML, Minnaar IA, Keegan KM, Clusella-Trullas S.

Evolution. 2019 Oct 10. doi: 10.1111/evo.13862. [Epub ahead of print]

PMID:
31598960
2.

Editorial Comment.

Keegan KA.

J Urol. 2019 Apr;201(4):749. doi: 10.1097/01.JU.0000554774.94661.e3. No abstract available.

PMID:
30947453
3.

Reliability of equine visual lameness classification.

Keegan KG.

Vet Rec. 2019 Jan 12;184(2):60-62. doi: 10.1136/vr.k5366. No abstract available.

PMID:
30635535
4.

Letter to the Editor: A response to 'What is lameness and what (or who) is the gold standard to detect it?'

Adair S, Baus M, Bell R, Boero M, Bussy C, Cardenas F, Casey T, Castro J, Davis W, Erskine M, Farr R, Fischer A Jr, Forbes B, Ford T, Genovese R, Gottschalk R, Hoge M, Honnas C, Hunter G, Joyce J, Kaneps A, Keegan K, Kramer J, Labens R, Lischer C, Marshall J, Oosterlinck M, Radue P, Redding R, Reed S, Rick M, Santschi E, Schoonover M, Schramme M, Schumacher J, Stephenson R, Thaler R, Nielsen JV, Wilson D.

Equine Vet J. 2019 Mar;51(2):270-272. doi: 10.1111/evj.13043. Epub 2018 Dec 20. No abstract available.

PMID:
30570777
5.

AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies.

Caenepeel S, Brown SP, Belmontes B, Moody G, Keegan KS, Chui D, Whittington DA, Huang X, Poppe L, Cheng AC, Cardozo M, Houze J, Li Y, Lucas B, Paras NA, Wang X, Taygerly JP, Vimolratana M, Zancanella M, Zhu L, Cajulis E, Osgood T, Sun J, Damon L, Egan RK, Greninger P, McClanaghan JD, Gong J, Moujalled D, Pomilio G, Beltran P, Benes CH, Roberts AW, Huang DC, Wei A, Canon J, Coxon A, Hughes PE.

Cancer Discov. 2018 Dec;8(12):1582-1597. doi: 10.1158/2159-8290.CD-18-0387. Epub 2018 Sep 25. Erratum in: Cancer Discov. 2019 Jul;9(7):980.

PMID:
30254093
6.

KBase: The United States Department of Energy Systems Biology Knowledgebase.

Arkin AP, Cottingham RW, Henry CS, Harris NL, Stevens RL, Maslov S, Dehal P, Ware D, Perez F, Canon S, Sneddon MW, Henderson ML, Riehl WJ, Murphy-Olson D, Chan SY, Kamimura RT, Kumari S, Drake MM, Brettin TS, Glass EM, Chivian D, Gunter D, Weston DJ, Allen BH, Baumohl J, Best AA, Bowen B, Brenner SE, Bun CC, Chandonia JM, Chia JM, Colasanti R, Conrad N, Davis JJ, Davison BH, DeJongh M, Devoid S, Dietrich E, Dubchak I, Edirisinghe JN, Fang G, Faria JP, Frybarger PM, Gerlach W, Gerstein M, Greiner A, Gurtowski J, Haun HL, He F, Jain R, Joachimiak MP, Keegan KP, Kondo S, Kumar V, Land ML, Meyer F, Mills M, Novichkov PS, Oh T, Olsen GJ, Olson R, Parrello B, Pasternak S, Pearson E, Poon SS, Price GA, Ramakrishnan S, Ranjan P, Ronald PC, Schatz MC, Seaver SMD, Shukla M, Sutormin RA, Syed MH, Thomason J, Tintle NL, Wang D, Xia F, Yoo H, Yoo S, Yu D.

Nat Biotechnol. 2018 Jul 6;36(7):566-569. doi: 10.1038/nbt.4163. No abstract available.

7.

Response to Letter to the Editor: Do we have to redefine lameness in the era of quantitative gait analysis.

Adair S, Baus M, Belknap J, Bell R, Boero M, Bussy C, Cardenas F, Casey T, Castro J, Davis W, Erskine M, Farr R, Fischer T, Forbes B, Ford T, Genovese R, Gottschalk R, Hoge M, Honnas C, Hunter G, Joyce J, Kaneps A, Keegan K, Kramer J, Lischer C, Marshall J, Oosterlinck M, Radue P, Redding R, Reed SK, Rick M, Santschi E, Schoonover M, Schramme M, Schumacher J, Stephenson R, Thaler R, Vedding Neilsen J, Wilson DA.

Equine Vet J. 2018 May;50(3):415-417. doi: 10.1111/evj.12820. No abstract available.

PMID:
29633362
8.

Oncologic outcomes in patients with nonurothelial bladder cancer.

Patel SG, Weiner AB, Keegan K, Morgan T.

Indian J Urol. 2018 Jan-Mar;34(1):39-44. doi: 10.4103/iju.IJU_115_17.

9.

The prognostic effect of salvage surgery and radiotherapy in patients with recurrent primary urethral carcinoma.

Gakis G, Schubert T, Morgan TM, Daneshmand S, Keegan KA, Mischinger J, Clayman RH, Brisuda A, Ali-El-Dein B, Galland S, Gregg J, Balci M, Olugbade K Jr, Rink M, Fritsche HM, Burger M, Babjuk M, Stenzl A, Thalmann GN, Kübler H, Efstathiou JA.

Urol Oncol. 2018 Jan;36(1):10.e7-10.e14. doi: 10.1016/j.urolonc.2017.09.012. Epub 2017 Oct 18.

PMID:
29055518
10.

Creation and Execution of a Novel Anesthesia Perioperative Care Service at a Veterans Affairs Hospital.

Alvis BD, King AB, Pandharipande PP, Weavind LM, Avila K, Leisy PJ, Ajmal M, McHugh M, Keegan KA, Baker DA, Walia A, Hughes CG.

Anesth Analg. 2017 Nov;125(5):1526-1531. doi: 10.1213/ANE.0000000000001930.

PMID:
28632542
11.

Parent-to-parent peer support for parents of children with a disability: A mixed method study.

Bray L, Carter B, Sanders C, Blake L, Keegan K.

Patient Educ Couns. 2017 Aug;100(8):1537-1543. doi: 10.1016/j.pec.2017.03.004. Epub 2017 Mar 6.

12.

Exploring stakeholder experiences of interprofessional teamwork in sex development outpatient clinics.

Sanders C, Edwards Z, Keegan K.

J Interprof Care. 2017 May;31(3):376-385. doi: 10.1080/13561820.2016.1272559. Epub 2017 Feb 17.

PMID:
28276848
13.

PI3Kδ inhibitor idelalisib in combination with BTK inhibitor ONO/GS-4059 in diffuse large B cell lymphoma with acquired resistance to PI3Kδ and BTK inhibitors.

Yahiaoui A, Meadows SA, Sorensen RA, Cui ZH, Keegan KS, Brockett R, Chen G, Quéva C, Li L, Tannheimer SL.

PLoS One. 2017 Feb 8;12(2):e0171221. doi: 10.1371/journal.pone.0171221. eCollection 2017.

14.

Discovery of a Phosphoinositide 3-Kinase (PI3K) β/δ Inhibitor for the Treatment of Phosphatase and Tensin Homolog (PTEN) Deficient Tumors: Building PI3Kβ Potency in a PI3Kδ-Selective Template by Targeting Nonconserved Asp856.

Perreault S, Chandrasekhar J, Cui ZH, Evarts J, Hao J, Kaplan JA, Kashishian A, Keegan KS, Kenney T, Koditek D, Lad L, Lepist EI, McGrath ME, Patel L, Phillips B, Therrien J, Treiberg J, Yahiaoui A, Phillips G.

J Med Chem. 2017 Feb 23;60(4):1555-1567. doi: 10.1021/acs.jmedchem.6b01821. Epub 2017 Feb 7.

PMID:
28106991
15.

Measurement of fidgeting in patients with anorexia nervosa using a novel shoe-based monitor.

Belak L, Gianini L, Klein DA, Sazonov E, Keegan K, Neustadt E, Walsh BT, Attia E.

Eat Behav. 2017 Jan;24:45-48. doi: 10.1016/j.eatbeh.2016.11.005. Epub 2016 Dec 9.

16.

An attempt to detect lameness in galloping horses by use of body-mounted inertial sensors.

Lopes MA, Dearo AC, Lee A, Reed SK, Kramer J, Pai PF, Yonezawa Y, Maki H, Morgan TL, Wilson DA, Keegan KG.

Am J Vet Res. 2016 Oct;77(10):1121-31. doi: 10.2460/ajvr.77.10.1121.

PMID:
27668584
17.

Oncological Outcomes of Patients with Concomitant Bladder and Urethral Carcinoma.

Gakis G, Efstathiou JA, Daneshmand S, Keegan KA, Clayman RH, Hrbacek J, Ali-El-Dein B, Zaid HB, Schubert T, Mischinger J, Todenhöfer T, Galland S, Olugbade K Jr, Rink M, Fritsche HM, Burger M, Chang SS, Babjuk M, Thalmann GN, Stenzl A, Morgan TM.

Urol Int. 2016;97(2):134-41. doi: 10.1159/000448335. Epub 2016 Jul 28.

18.

Associations of force plate and body-mounted inertial sensor measurements for identification of hind limb lameness in horses.

Bell RP, Reed SK, Schoonover MJ, Whitfield CT, Yonezawa Y, Maki H, Pai PF, Keegan KG.

Am J Vet Res. 2016 Apr;77(4):337-45. doi: 10.2460/ajvr.77.4.337.

PMID:
27027831
19.

MG-RAST, a Metagenomics Service for Analysis of Microbial Community Structure and Function.

Keegan KP, Glass EM, Meyer F.

Methods Mol Biol. 2016;1399:207-33. doi: 10.1007/978-1-4939-3369-3_13.

PMID:
26791506
20.

Microbial Metabolism Shifts Towards an Adverse Profile with Supplementary Iron in the TIM-2 In vitro Model of the Human Colon.

Kortman GA, Dutilh BE, Maathuis AJ, Engelke UF, Boekhorst J, Keegan KP, Nielsen FG, Betley J, Weir JC, Kingsbury Z, Kluijtmans LA, Swinkels DW, Venema K, Tjalsma H.

Front Microbiol. 2016 Jan 6;6:1481. doi: 10.3389/fmicb.2015.01481. eCollection 2015.

21.

Role of consolidative surgical therapy in patients with locally advanced or regionally metastatic bladder cancer.

Tyson MD, Chang SS, Keegan KA.

Bladder (San Franc). 2016;3(2). pii: e26. doi: 10.14440/bladder.2016.89.

22.

The MG-RAST metagenomics database and portal in 2015.

Wilke A, Bischof J, Gerlach W, Glass E, Harrison T, Keegan KP, Paczian T, Trimble WL, Bagchi S, Grama A, Chaterji S, Meyer F.

Nucleic Acids Res. 2016 Jan 4;44(D1):D590-4. doi: 10.1093/nar/gkv1322. Epub 2015 Dec 9.

23.

Metagenomic analysis of planktonic microbial consortia from a non-tidal urban-impacted segment of James River.

Brown BL, LePrell RV, Franklin RB, Rivera MC, Cabral FM, Eaves HL, Gardiakos V, Keegan KP, King TL.

Stand Genomic Sci. 2015 Sep 19;10:65. doi: 10.1186/s40793-015-0062-5. eCollection 2015.

24.

Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma.

Gakis G, Morgan TM, Efstathiou JA, Keegan KA, Mischinger J, Todenhoefer T, Schubert T, Zaid HB, Hrbacek J, Ali-El-Dein B, Clayman RH, Galland S, Olugbade K Jr, Rink M, Fritsche HM, Burger M, Chang SS, Babjuk M, Thalmann GN, Stenzl A, Daneshmand S.

World J Urol. 2016 Jan;34(1):97-103. doi: 10.1007/s00345-015-1583-7. Epub 2015 May 17.

PMID:
25981402
25.

Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma.

Gakis G, Morgan TM, Daneshmand S, Keegan KA, Todenhöfer T, Mischinger J, Schubert T, Zaid HB, Hrbacek J, Ali-El-Dein B, Clayman RH, Galland S, Olugbade K, Rink M, Fritsche HM, Burger M, Chang SS, Babjuk M, Thalmann GN, Stenzl A, Efstathiou JA.

Ann Oncol. 2015 Aug;26(8):1754-9. doi: 10.1093/annonc/mdv230. Epub 2015 May 12.

PMID:
25969370
26.

A Randomized Controlled Trial for Pain Control in Laparoscopic Urologic Surgery: 0.25% Bupivacaine Versus Long-Acting Liposomal Bupivacaine.

Knight RB, Walker PW, Keegan KA, Overholser SM, Baumgartner TS, Ebertowski JS 2nd, Aden JK, White MA.

J Endourol. 2015 Sep;29(9):1019-24. doi: 10.1089/end.2014.0769. Epub 2015 Jun 5.

PMID:
25897552
27.

Head and pelvic movement asymmetry during lungeing in horses with symmetrical movement on the straight.

Rhodin M, Roepstorff L, French A, Keegan KG, Pfau T, Egenvall A.

Equine Vet J. 2016 May;48(3):315-20. doi: 10.1111/evj.12446. Epub 2015 May 29.

28.

Increasing use of observation among men at low risk for prostate cancer mortality.

Ritch CR, Graves AJ, Keegan KA, Ni S, Bassett JC, Chang SS, Resnick MJ, Penson DF, Barocas DA.

J Urol. 2015 Mar;193(3):801-6. doi: 10.1016/j.juro.2014.08.102. Epub 2014 Sep 6.

29.

Climate change and forest fires synergistically drive widespread melt events of the Greenland Ice Sheet.

Keegan KM, Albert MR, McConnell JR, Baker I.

Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):7964-7. doi: 10.1073/pnas.1405397111. Epub 2014 May 19.

30.

Synthesis and structure-activity relationship of trisubstituted thiazoles as Cdc7 kinase inhibitors.

Reichelt A, Bailis JM, Bartberger MD, Yao G, Shu H, Kaller MR, Allen JG, Weidner MF, Keegan KS, Dao JH.

Eur J Med Chem. 2014 Jun 10;80:364-82. doi: 10.1016/j.ejmech.2014.04.013. Epub 2014 Apr 5.

PMID:
24793884
31.

Discovery of AMG 925, a FLT3 and CDK4 dual kinase inhibitor with preferential affinity for the activated state of FLT3.

Li Z, Wang X, Eksterowicz J, Gribble MW Jr, Alba GQ, Ayres M, Carlson TJ, Chen A, Chen X, Cho R, Connors RV, DeGraffenreid M, Deignan JT, Duquette J, Fan P, Fisher B, Fu J, Huard JN, Kaizerman J, Keegan KS, Li C, Li K, Li Y, Liang L, Liu W, Lively SE, Lo MC, Ma J, McMinn DL, Mihalic JT, Modi K, Ngo R, Pattabiraman K, Piper DE, Queva C, Ragains ML, Suchomel J, Thibault S, Walker N, Wang X, Wang Z, Wanska M, Wehn PM, Weidner MF, Zhang AJ, Zhao X, Kamb A, Wickramasinghe D, Dai K, McGee LR, Medina JC.

J Med Chem. 2014 Apr 24;57(8):3430-49. doi: 10.1021/jm500118j. Epub 2014 Apr 2.

PMID:
24641103
32.

Increasing utilization of neoadjuvant chemotherapy for muscle-invasive bladder cancer in the United States.

Keegan KA, Zaid HB, Patel SG, Chang SS.

Curr Urol Rep. 2014 Apr;15(4):394. doi: 10.1007/s11934-014-0394-5. Review.

33.

Preclinical evaluation of AMG 925, a FLT3/CDK4 dual kinase inhibitor for treating acute myeloid leukemia.

Keegan K, Li C, Li Z, Ma J, Ragains M, Coberly S, Hollenback D, Eksterowicz J, Liang L, Weidner M, Huard J, Wang X, Alba G, Orf J, Lo MC, Zhao S, Ngo R, Chen A, Liu L, Carlson T, Quéva C, McGee LR, Medina J, Kamb A, Wickramasinghe D, Dai K.

Mol Cancer Ther. 2014 Apr;13(4):880-9. doi: 10.1158/1535-7163.MCT-13-0858. Epub 2014 Feb 13.

34.

The Hospital Microbiome Project: Meeting report for the 2nd Hospital Microbiome Project, Chicago, USA, January 15(th), 2013.

Shogan BD, Smith DP, Packman AI, Kelley ST, Landon EM, Bhangar S, Vora GJ, Jones RM, Keegan K, Stephens B, Ramos T, Kirkup BC Jr, Levin H, Rosenthal M, Foxman B, Chang EB, Siegel J, Cobey S, An G, Alverdy JC, Olsiewski PJ, Martin MO, Marrs R, Hernandez M, Christley S, Morowitz M, Weber S, Gilbert J.

Stand Genomic Sci. 2013 Jul 25;8(3):571-9. doi: 10.4056/sigs.4187859. eCollection 2013 Jul 30. No abstract available.

35.

Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides.

Reardon ZD, Patel SG, Zaid HB, Stimson CJ, Resnick MJ, Keegan KA, Barocas DA, Chang SS, Cookson MS.

Eur Urol. 2015 Jan;67(1):165-170. doi: 10.1016/j.eururo.2014.01.009. Epub 2014 Jan 23.

36.

Bacterial community structure and functional contributions to emergence of health or necrotizing enterocolitis in preterm infants.

Claud EC, Keegan KP, Brulc JM, Lu L, Bartels D, Glass E, Chang EB, Meyer F, Antonopoulos DA.

Microbiome. 2013 Jul 10;1(1):20. doi: 10.1186/2049-2618-1-20.

37.

Neurological impairment in a surviving twin following intrauterine fetal demise of the co-twin: a case study.

Forrester KR, Keegan KM, Schmidt JW.

J Neonatal Perinatal Med. 2013;6(1):83-8. doi: 10.3233/NPM-1364512.

PMID:
24246463
38.

A metagenomics portal for a democratized sequencing world.

Wilke A, Glass EM, Bartels D, Bischof J, Braithwaite D, D'Souza M, Gerlach W, Harrison T, Keegan K, Matthews H, Kottmann R, Paczian T, Tang W, Trimble WL, Yilmaz P, Wilkening J, Desai N, Meyer F.

Methods Enzymol. 2013;531:487-523. doi: 10.1016/B978-0-12-407863-5.00022-8.

PMID:
24060134
39.

Blood loss associated with radical cystectomy: a prospective, randomized study comparing Impact LigaSure vs. stapling device.

Thompson IM 3rd, Kappa SF, Morgan TM, Barocas DA, Bischoff CJ, Keegan KA, Stratton KL, Clark PE, Resnick MJ, Smith JA Jr, Cookson MS, Chang SS.

Urol Oncol. 2014 Jan;32(1):45.e11-5. doi: 10.1016/j.urolonc.2013.06.006. Epub 2013 Sep 17.

40.

Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy.

Ark JT, Keegan KA, Barocas DA, Morgan TM, Resnick MJ, You C, Cookson MS, Penson DF, Davis R, Clark PE, Smith JA Jr, Chang SS.

BJU Int. 2014 Jun;113(6):894-9. doi: 10.1111/bju.12245. Epub 2014 Apr 3.

41.

The Hospital Microbiome Project: Meeting Report for the 1st Hospital Microbiome Project Workshop on sampling design and building science measurements, Chicago, USA, June 7th-8th 2012.

Smith D, Alverdy J, An G, Coleman M, Garcia-Houchins S, Green J, Keegan K, Kelley ST, Kirkup BC, Kociolek L, Levin H, Landon E, Olsiewski P, Knight R, Siegel J, Weber S, Gilbert J.

Stand Genomic Sci. 2013 Apr 15;8(1):112-7. doi: 10.4056/sigs.3717348. eCollection 2013 Apr 15.

42.

Hindlimb kinematics before and after laser fibrotomy in horses with fibrotic myopathy.

Janicek J, Lopes MA, Wilson DA, Reed S, Keegan KG.

Equine Vet J Suppl. 2012 Dec;(43):126-31.

PMID:
23447892
43.

Single intranasal neuropeptide Y infusion attenuates development of PTSD-like symptoms to traumatic stress in rats.

Serova LI, Tillinger A, Alaluf LG, Laukova M, Keegan K, Sabban EL.

Neuroscience. 2013 Apr 16;236:298-312. doi: 10.1016/j.neuroscience.2013.01.040. Epub 2013 Jan 30.

PMID:
23376740
44.

A 57-year-old man with a history of prostatectomy and pelvic irradiation presents with recurrent urinary tract infections, hematuria, and pelvic pain.

Moore DC, Keegan KA, Resnick MJ, Eisenberg R, Holt GE, Cookson MS.

Urology. 2013 Feb;81(2):221-5. doi: 10.1016/j.urology.2012.10.037. No abstract available.

45.

Comparison of a body-mounted inertial sensor system-based method with subjective evaluation for detection of lameness in horses.

Keegan KG, Wilson DA, Kramer J, Reed SK, Yonezawa Y, Maki H, Pai PF, Lopes MA.

Am J Vet Res. 2013 Jan;74(1):17-24. doi: 10.2460/ajvr.74.1.17.

PMID:
23270341
46.

Editorial comment.

Keegan KA.

J Urol. 2013 Jan;189(1):85. doi: 10.1016/j.juro.2012.08.262. Epub 2012 Nov 16. No abstract available.

PMID:
23164380
47.

Volume outcomes of cystectomy--is it the surgeon or the setting?

Morgan TM, Barocas DA, Keegan KA, Cookson MS, Chang SS, Ni S, Clark PE, Smith JA Jr, Penson DF.

J Urol. 2012 Dec;188(6):2139-44. doi: 10.1016/j.juro.2012.08.042. Epub 2012 Oct 18.

PMID:
23083864
48.

Salvage robotic assisted laparoscopic radical prostatectomy: a single institution, 5-year experience.

Kaffenberger SD, Keegan KA, Bansal NK, Morgan TM, Tang DH, Barocas DA, Penson DF, Davis R, Clark PE, Chang SS, Cookson MS, Herrell SD, Smith JA Jr.

J Urol. 2013 Feb;189(2):507-13. doi: 10.1016/j.juro.2012.09.057. Epub 2012 Sep 20.

49.

ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder.

Gakis G, Efstathiou J, Lerner SP, Cookson MS, Keegan KA, Guru KA, Shipley WU, Heidenreich A, Schoenberg MP, Sagaloswky AI, Soloway MS, Stenzl A; International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012.

Eur Urol. 2013 Jan;63(1):45-57. doi: 10.1016/j.eururo.2012.08.009. Epub 2012 Aug 14. Review.

PMID:
22917985
50.

Short-read reading-frame predictors are not created equal: sequence error causes loss of signal.

Trimble WL, Keegan KP, D'Souza M, Wilke A, Wilkening J, Gilbert J, Meyer F.

BMC Bioinformatics. 2012 Jul 28;13:183. doi: 10.1186/1471-2105-13-183.

Supplemental Content

Loading ...
Support Center